Open AccessTHE USE OF HYPOMETHYLATING DRUGS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME IN VIEW OF THE CURRENT CONCEPTION OF THE MECHANISMS OF DISEASE DEVELOPMENT
Author(s) -
Halyna Starodub,
N. V. Goryainova,
А. И. Гордиенко,
О. В. Басова,
Nataliia Tretiak,
V. O. Kubarova
Publication year - 2016
Publication title -
hematology and blood transfusion interdepartamental collection
Language(s) - English
Resource type - Journals
ISSN - 0435-1991
DOI - 10.33741/0435-1991.40.23
Subject(s) - myelodysplastic syndromes , disease , medicine , current (fluid) , hypomethylating agent , intensive care medicine , oncology , biology , genetics , dna methylation , bone marrow , electrical engineering , engineering , gene expression , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom